中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2013年
23期
57-58,74
,共3页
高姗%张惠君%朱海燕%张秋业
高姍%張惠君%硃海燕%張鞦業
고산%장혜군%주해연%장추업
系统性红斑狼疮%儿童%淋巴细胞亚群
繫統性紅斑狼瘡%兒童%淋巴細胞亞群
계통성홍반랑창%인동%림파세포아군
Systemic lupus erythematosus%Child%Lymphocyte subsets
目的:探讨系统性红斑狼疮(SLE)患儿外周血淋巴细胞亚群变化特征。方法选择24例SLE病儿和20例健康儿童为研究对象,应用流式细胞术(FCM)检测外周血的淋巴细胞亚群,对比分析两组检测结果。结果SLE患儿外周血CD4+CD25+T细胞、自然杀伤(NK)细胞百分率较对照组明显降低(t=2.480,3.773;P<0.05),CD8+T细胞、活化T细胞和B细胞百分率明显升高(t=3.470,4.779,2.480;P<0.05或P<0.01)。结论SLE患儿外周血淋巴细胞亚群紊乱,调节性T细胞和NK细胞减少、B细胞增多和T细胞活化增强,在SLE发病机制中可能起重要作用。
目的:探討繫統性紅斑狼瘡(SLE)患兒外週血淋巴細胞亞群變化特徵。方法選擇24例SLE病兒和20例健康兒童為研究對象,應用流式細胞術(FCM)檢測外週血的淋巴細胞亞群,對比分析兩組檢測結果。結果SLE患兒外週血CD4+CD25+T細胞、自然殺傷(NK)細胞百分率較對照組明顯降低(t=2.480,3.773;P<0.05),CD8+T細胞、活化T細胞和B細胞百分率明顯升高(t=3.470,4.779,2.480;P<0.05或P<0.01)。結論SLE患兒外週血淋巴細胞亞群紊亂,調節性T細胞和NK細胞減少、B細胞增多和T細胞活化增彊,在SLE髮病機製中可能起重要作用。
목적:탐토계통성홍반랑창(SLE)환인외주혈림파세포아군변화특정。방법선택24례SLE병인화20례건강인동위연구대상,응용류식세포술(FCM)검측외주혈적림파세포아군,대비분석량조검측결과。결과SLE환인외주혈CD4+CD25+T세포、자연살상(NK)세포백분솔교대조조명현강저(t=2.480,3.773;P<0.05),CD8+T세포、활화T세포화B세포백분솔명현승고(t=3.470,4.779,2.480;P<0.05혹P<0.01)。결론SLE환인외주혈림파세포아군문란,조절성T세포화NK세포감소、B세포증다화T세포활화증강,재SLE발병궤제중가능기중요작용。
Objective To study the characteristics of changes of peripheral blood lymphocyte subsets in children with systemic lupus erythematosus(SLE). Methods 24 children with SLE and 20 healthy children were selected as the study objects, the peripheral blood lymphocyte subsets in children were detected by using the FCM, then the test results of the two groups were analyzed and compared. Results The percentages of peripheral blood CD4+CD25+ T cells and NK cells in children with SLE were significantly lower than those in the control group(t=2.480,3.773, P<0.05), while the percentages of CD8+ T cells, activated T cells and B cells in children with SLE were significantly higher(t=3.470, 4.779,2.480, P<0.05 or P<0.01). Conclusion The dysfunctional peripheral blood lymphocyte subsets in children with SLE, decreasing regulatory T cells and NK cells, increasing B cells and excessive activation of T cells, which may play an important role in the pathogenesis of SLE.